Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent Deferred RevenueCurrent LeasesCurrent TaxesFinished GoodsInventoryLiabilities and Shareholders EquityLong-Term Deferred TaxNon-Current AssetsNon-Current DebtNotes PayablesOperating LeasesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPensionPrepaid AssetsProperty, Plant & Equipment (Net)Raw MaterialsReceivablesRetained EarningsShareholder's EquityShort term DebtShort-term InvestmentsTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current LiabilitiesTreasury SharesWork In Process
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Natural Alternatives International (NAII) Cash & Equivalents (2016 - 2025)

Natural Alternatives International's Cash & Equivalents history spans 16 years, with the latest figure at $3.8 million for Q4 2025.

  • For Q4 2025, Cash & Equivalents fell 56.68% year-over-year to $3.8 million; the TTM value through Dec 2025 reached $3.8 million, down 56.68%, while the annual FY2025 figure was $12.3 million, 2.87% up from the prior year.
  • Cash & Equivalents for Q4 2025 was $3.8 million at Natural Alternatives International, down from $7.7 million in the prior quarter.
  • Across five years, Cash & Equivalents topped out at $32.1 million in Q2 2021 and bottomed at $3.8 million in Q4 2025.
  • The 5-year median for Cash & Equivalents is $13.2 million (2022), against an average of $15.3 million.
  • The largest annual shift saw Cash & Equivalents surged 35.72% in 2023 before it tumbled 56.68% in 2025.
  • A 5-year view of Cash & Equivalents shows it stood at $19.4 million in 2021, then crashed by 34.0% to $12.8 million in 2022, then rose by 29.92% to $16.6 million in 2023, then crashed by 47.8% to $8.7 million in 2024, then crashed by 56.68% to $3.8 million in 2025.
  • Per Business Quant, the three most recent readings for NAII's Cash & Equivalents are $3.8 million (Q4 2025), $7.7 million (Q3 2025), and $12.3 million (Q2 2025).